PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7981011-13	1994	Treatment with quinapril was associated with a significant rise in plasma renin activity (PRA) of 8.83 ng AI ml-1 h-1 (95% C.I.	Quinapril	15-24	renin	Homo sapiens	74-79	
8743525-1	1996	The effects of inhibition of the renin-angiotensin system with quinapril on adrenergic transmission were determined in 18 patients with moderate essential hypertension.	Quinapril	63-72	renin	Homo sapiens	33-38	
11791032-12	2002	In contrast, the combination therapy with losartan and quinapril, which results in a higher degree of inhibition of the renin-angiotensin system, could suppress the cardiac sympathetic activity effectively.	Quinapril	55-64	renin	Homo sapiens	120-125	
10676106-7	1999	It is concluded that treatment with quinapril for 1 year in addition to controlling blood pressure also reduced left ventricular mass probably by a favourable effect on renin-angiotensin-aldosterone system.	Quinapril	36-45	renin	Homo sapiens	169-174	
9857879-9	1998	Quinapril produced a substantial rise in renin (p = 0.01) but did not significantly affect either PAI-1 or tPA.	Quinapril	0-9	renin	Homo sapiens	41-46	
2197098-8	1990	Inhibition of the renin-angiotensin system by quinapril was shown by a marked decrease in serum ACE activity and a several-fold increase in plasma renin activity (PRA).	Quinapril	46-55	renin	Homo sapiens	18-23	
2197098-8	1990	Inhibition of the renin-angiotensin system by quinapril was shown by a marked decrease in serum ACE activity and a several-fold increase in plasma renin activity (PRA).	Quinapril	46-55	renin	Homo sapiens	147-152	
2539762-4	1989	In addition, plasma renin activity increased and aldosterone and angiotensin II concentrations decreased following single or multiple doses of quinapril.	Quinapril	143-152	renin	Homo sapiens	20-25